Abstract
Following the Anthrax bioterrorism attacks in the US in 2001, the Korean government established comprehensive countermeasures against bioterrorism. These measures included the government assuming management of all infectious agents that cause diseases, including smallpox, anthrax, plaque, botulism, and the causative agents of viral hemorrhagic fevers (ebola fever, marburg fever, and lassa fever) for national security. In addition, the Korean government is reinforcing the ability to prepare and respond to bioterrorism. Some of the measures being implemented include revising the laws and guidelines that apply to the use of infectious agents, the construction and operation of dual surveillance systems for bioterrorism, stockpiling and managing products necessary to respond to an emergency (smallpox vaccine, antibiotics, etc.) and vigorously training emergency room staff and heath workers to ensure they can respond appropriately. In addition, the government's measures include improved public relations, building and maintaining international cooperation, and developing new vaccines and drugs for treatments of infectious agents used to create bioweapons.
Citations
Citations to this article as recorded by
- Network Experiences from a Cross-Sector Biosafety Level-3 Laboratory Collaboration: A Swedish Forum for Biopreparedness Diagnostics
Johanna Thelaus, Anna Lindberg, Susanne Thisted Lambertz, Mona Byström, Mats Forsman, Hans Lindmark, Rickard Knutsson, Viveca Båverud, Andreas Bråve, Pontus Jureen, Annelie Lundin Zumpe, Öjar Melefors
Health Security.2017; 15(4): 384. CrossRef - Pre-PCR Processing in Bioterrorism Preparedness: Improved Diagnostic Capabilities for Laboratory Response Networks
Johannes Hedman, Rickard Knutsson, Ricky Ansell, Peter Rådström, Birgitta Rasmusson
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science.2013; 11(S1): S87. CrossRef - Harmonization of European Laboratory Response Networks by Implementing CWA 15793: Use of a Gap Analysis and an “Insider” Exercise as Tools
Bo Sundqvist, Ulrika Allard Bengtsson, Henk J. Wisselink, Ben P. H. Peeters, Bart van Rotterdam, Evelien Kampert, Sándor Bereczky, N. G. Johan Olsson, Åsa Szekely Björndal, Sylvie Zini, Sébastien Allix, Rickard Knutsson
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science.2013; 11(S1): S36. CrossRef - Shelf-Life Extension Program (SLEP) as a Significant Contributor to Strategic National Stockpile Maintenance: The Israeli Experience with Ciprofloxacin
Moran Bodas, Landschaft Yuval, Ron Zadok, Zippora Hess, Batya Haran, Mimi Kaplan, Arik Eisenkraft
Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science.2012; 10(2): 182. CrossRef - The Current Status of Bioterrorism Education in Health-related Colleges -In the Professors of the Health-related Colleges-
Byung-Chul Chun, Kyeong-Uoon Kim, Jee-Hee Kim, Jin-Woo Kim, Sang-Gyun Roh
Journal of the Korea Academia-Industrial cooperation Society.2012; 13(2): 710. CrossRef - Preparedness of Young Male Physicians for Biological Terrorism and Warfare in South Korea
JH Ahn, JW Chung, CW Kim, DH Lee
Hong Kong Journal of Emergency Medicine.2012; 19(1): 18. CrossRef - A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines
Cheryl X. Zhang, Christian Sauder, Tahir Malik, Steven A. Rubin
Biologicals.2010; 38(2): 278. CrossRef
KSPM
